Chest 2020 Jul
Somatostatin Analogs Improve Respiratory Symptoms in Patients With Diffuse Idiopathic Neuroendocrine Cell Hyperplasia.
Related Questions
New answer by Medical Oncologist at Mayo Clinic (December 28, 2022)
The key question is why there is a reason to change the treatment... Is it for worsening symptoms or progressive disease with overt lung NET development or progression of know...
Does your management change if symptomatic or asymptomatic?
New answer by Medical Oncologist at Mayo Clinic (January 4, 2023)
The management of patients with DIPNECH is predominantly symptomatic but DIPNECH is a chronic disease, often with significant respiratory symptoms such as dyspnea and cough bu...